Baupost Group - IDENIX PHARMACEUTICALS INC ownership

IDENIX PHARMACEUTICALS INC's ticker is IDIX and the CUSIP is 45166R204. A total of 98 filers reported holding IDENIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baupost Group ownership history of IDENIX PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$1,269,560,000
+319.2%
53,331,1090.0%20.68%
+182.4%
Q1 2014$302,844,000
+37.2%
53,331,109
+44.5%
7.32%
+17.0%
Q4 2013$220,727,000
+43.4%
36,910,868
+24.4%
6.25%
+42.1%
Q3 2013$153,965,000
+59.3%
29,665,693
+10.8%
4.40%
+83.1%
Q2 2013$96,629,00026,767,0002.40%
Other shareholders

There were no reported owners of IDENIX PHARMACEUTICALS INC in Q1 2014.

NameSharesValueWeighting ↓
View complete list of IDENIX PHARMACEUTICALS INC shareholders